[1] Kamar N, Selves J, Mansuy JM, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med, 2008,358: 811-817.
[2] Colson P, Dhiver C, Poizot-Martin I, et al. Acute and chronic hepatitis E in patients infected with human immunodeficiency virus. J Viral Hepat, 2011,18: 227-228.
[3] Wedemeyer H, Pischke S, Manns MP. Pathogenesis and treatment of hepatitis E virus infection. Gastroenterology, 2012, 142: 1388-1397.
[4] Kamar N, Bendall R, Legrand-Abravanel F, et al. Hepatitis E. Lancet, 2012, 379: 2477-2488.
[5] Jia Z, Yi Y, Liu J, et al. Epidemiology of hepatitis E virus in China: results from the Third National Viral Hepatitis Prevalence Survey, 2005-2006. PLoS One, 2014, 9: e110837.
[6] Gao S, Li D, Zha E,et al. Surveillance of hepatitis E virus contamination in shellfish in China. Int J Environ Res Public Health, 2015, 12: 2026-2036.
[7] Liang H, Su S, Deng S, et al. The prevalence of hepatitis E virus infections among swine, swine farmers and the general population in Guangdong Province, China. PLoS One, 2014,9: e88106.
[8] Yan YJ, Zhang W, Shen Q, et al. Prevalence of four different subgenotypes of genotype 4 hepatitis E virus among swine in the Shanghai area of China. Acta Veterinaria Scandinavica, 2008, 50: 12.
[9] Müllhaupt B, Niederhauser C. Hepatitis E blood donor screening - More than a mere drop in the ocean? J Hepatol, 2018, 69: 8-10.
[10] Zhang J, Zhang X F, Huang S J, et al. Long-term efficacy of a hepatitis E vaccine. N Engl J Med, 2015, 372: 914-922. |
